We are grateful to Schillaci and Pucci for their interest in our work 1 and we appreciate the opportunity to answer the question that they put forward.
Schillaci and Pucci 2 hypothesized that in our study previous anti-hypertensive treatment might have played a confounding role in the evaluation of the effect of gender on the relation between the metabolic syndrome (MetS) and left ventricular mass (LVM). However, as reported in our paper, 1 the analysis of the interaction term 'gender Â MetS' revealed no significant effect of sex on the association between MetS and LVM indexed for height 2.7 (LVMH 2.7 ), even after adjustment for previous pharmacological anti-hypertensive therapy. Furthermore, when we performed the same two-factor analysis of variance in the subset of patients never treated with anti-hypertensive drugs, as suggested by the authors, 2 we found again no significant effect of gender on the association between MetS and LVMH 2.7 , both before (F ¼ 2.3; P ¼ 0.13) and after adjustment for age, duration of hypertension and 24-h systolic blood pressure (F ¼ 2.4; P ¼ 0.12).
When in the same group of subjects the model was run again, after replacing, as dependent variable, LVMH 2.7 with LVM indexed for body surface area, we confirmed, even more convincingly, that gender has not a significant effect modifier of the relation between the MetS and LVM (F ¼ 0.67; P ¼ 0.41, before adjustment and F ¼ 0.7; P ¼ 0.39, after correction for age, duration of hypertension and 24-h systolic blood pressure).
It is important to note that in the study of Cuspidi et al. 3 quoted by the authors, even if the difference regarding LVM between subjects with and those without the MetS was more pronounced in women ( þ 17%) than in men ( þ 10%), the influence of gender on the relation between MetS and LVM was not formally tested by a multivariate statistical analysis. Moreover, in the same study, at variance with the findings of Schillaci et al., 4 it was observed that the MetS was associated with an increased LVM in both genders. 3 Similar results were obtained in the Atherosclerosis Risk in Communities study 5 and in the Pressioni Arteriose Monitorate E Loro Associazioni study. 6 At last, more recently, in the large population-based sample of the Prospective Investigation of the Vasculature in Uppsala Seniors study, 7 it was documented that LVM was increased in persons with the MetS, even accounting for covariates including intra-arterial blood pressure levels, and the interaction terms between sex and the MetS were not statistically significant. 7 Therefore, in agreement with Schillaci and Pucci, 2 we think that extensive and consistent data support the notion that the MetS has a deleterious impact on LVM in both men and women. However, we believe that there is not sufficient evidence to date demonstrating that gender has a significant influence on the relation between MetS and LVM. 
